Cerebral palsy epidemiology

Authors

  • Tamara Rodrigues Pato Faculdade de Ciências Médicas de Santos
  • Thais Rodrigues Pato Universidade de São Paulo. Faculdade de Medicina
  • Daniel Rúbio de Souza Universidade de São Paulo. Faculdade de Medicina
  • Heitor Pons Leite Faculdade de Ciências Médicas de Santos

DOI:

https://doi.org/10.5935/0104-7795.20020004

Keywords:

Cerebral Palsy/etiology, Cerebral Palsy/epidemiology, Life expectancy

Abstract

Introduction: there is a great interest in finding a cerebral palsy determinant ethiologic factor, that way, it could be possible to realize a profilatic approach for this injury. On literature, many risk factors are accused and some authors suggest that is a multifatorial disease. It was also searched about possible protector factors, life expectancy and the most commum causes of death, focusing on finding ways to prevent complications and to improve life quality. Methods and material: sistematic literature reviow based in 40 articles found in Bireme, Lilacs and Pubmed sites, beside two recente edition books. Results: the most mencioned risk factors were perinatal hypoxia, prematurity and mathernal intrauterine infeccion. Other factors are multiple births, choriomnionitis and thrombophilia. The use of corticosteroids on antenatal period was mencioned as a protector factor. Some authors also suggest a pre-eclampsia and magnesium sulfate administration, however a controversy still remains about this. The principal cause of death pointed were respiratory diseases, like pneumonia. Other causes are intestinal obstruction (f. e. volvo), pedestrian and motor accidents and drowning. Conclusion: it doesn´t exist a determinant factor to cerebral palsy. The hypoxia/ischemia perinatal have a large contribution comparing others factors, but it depend on the intensity and the period that occurs. There aren´t enough studies about protective factors to prove a true efficacy. The mainly causes of death are the repiratory diseases. It´s possible to reduce drowing and pedestrian accidents incidence based on orientation and rehabilitation.

Downloads

Download data is not yet available.

References

Christopher RP, Weber BJ. Reabilitação no paciente pediátrico. In: DeLisa JA, Gans BM. Tratado de medicina de reabilitação. 3rd ed. São Paulo: Manole; 2002. p. 995-6.

Gomes C, Santos CA, Ubiratam J, Silva A, Lianza S. Paralisia Cerebral. In: Lianza S. Medicina de reabilitação. 3rd ed. Rio de Janeiro: Guanabara/Koogan; 2001. p. 281-2.

Smith RA, Skelton M, Howard M, Levene M. Is thrombophilia a factor in the development of hemiplegic cerebral palsy? Dev Med Child Neurol. 2001;43(11):724-30.

Gaudet LM, Smith GN. Cerebral palsy and corioaminionitis: the inflamatory citokine link. Obstet Gynecol Surv. 2001;56:433-6.

Hunt RW, Badawi N, Laing S, Lam A. Pre-eclampsia: a predisposing factor for neonatal venous sinus thrombosis? Pediatr Neurol. 2001;25(3):242-6.

Cowan LD, Levinton A, Dammann O. New reaserch directions in neuroepidemiology. Epidemiol Rev. 2000;22:18-23.

Lumley J, Watson L, Watson M, Bower C. Modelling the potential impact of population-wide periconceptional folate/multivitamin supplementation on multiple births. BJOG. 2001;108(9):937-42.

Dammann O, Dammann CE, Allred EN, Veelken N. Fetal growth restriction is not associated with a reduced risk for bilateral spastic cerebral palsy in very-low-birthweight infants. Early Hum Dev. 2001;64(2):79-89.

Blair E. Risk factors of cerebral palsy. Scand J Soc Med. 1998;26:300-1.

Reading R, Eason J. Perinatal infeccion is an important risk factor for cerebral palsy in very-low-birthweigth infants. Dev Med Child Neurol. 2000;42:847-8.

Blickstein I, Weissman A. Estimating the risk of cerebral palsy after assisted conceptions. N Engl J Med. 1999;341:1313-4.

Stanley F, Blair E, Alberman E. Birth events and cerebral palsy: facts were not presented clearly. BMJ. 2001;322:50.

Strauss D, Cable W, Shavelle R. Causes of excess mortality in cerebral palsy. Dev Med Child Neurol. 1999;41:580-5.

Blair E, Watson L, Badawi N, Stanley FJ. Life expectancy among people with cerebral palsy in Western Australia. Dev Med Child Neurol. 2001;43(8):508-15.

Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 1996;276(22):1805-10.

Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol. 2000;183(3):717-25.

Dite GS, Bell R, Reddihough DS, Bessell C, Brennecke S, Sheedy M. Antenatal and perinatal antecedents of moderate and severe spastic cerebral palsy. Aust N Z J Obstet Gynaecol. 1998;38(4):377-83.

Nelson KB, Grether JK. Causes of cerebral palsy. Curr Opin Pediatr. 1999;11:487-9 1.

Schendel DE. Infection in pregnancy and cerebral palsy. J Am Med Wom Assoc. 2001;56:105-8.

Gray PH, Jones P, O' Callaghan MJ. Maternal antecedents for cerebral palsy in extremelly preterm babies: a case control study. Dev Med Child Neurol. 2001;43:580-5.

Banta DH, Thacker SB. Historical controversy in helth technology assessment: the case of eletronis fetal monitoring. Obstet Gynecol Surv. 2001;56:707-19.

Blair E. Trends in cerebral palsy. Indian J Pediatr. 2001;68:433-8.

Wilson-Costello D. Risk factors for neurologic impairment among very-low-birthweigth infantes. Semin Pediatr Neurol. 2001;8:120-6.

Vexler ZS, Ferriero DM. Molecular and biochemical mechanisms of perinatal brain injury. Semin Neonatol. 2001;6:99-108.

Pettersen MC, Palmer FB. Advances in prevention and treatment of cerebral palsy. Ment Retard Dev Disabil Res Rev. 2001;7:30-7.

Amor DJ, Craig JE, Delatycki MB, et al. Genetic factors in athetoid cerebral palsy. J Child Neurol. 2001;16:793-7.

Nelson KB, Willoughby RE. Infection, inflammation and the risk of cerebral palsy. Curr Opin Neurol. 2000;13:133-9.

Saliba E, Marret S. Cerebral white damage in preterm infant: pathophysiology and the risk factors. Semin Neonatol. 2001;6:121-33.

Foster-Barber A, Dickens B, Ferriero DM. Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome. Dev Neurosci. 2001;23:213-8.

Dizon-Townson DS. Preterm labour and delivery: a genetic predisposition. Paediatr Perinat Epidemiol. 2001;15:57- 62.

O'Shea TM, Kothadia JM, Roberts DD, Dillard RG. Perinatal events and the risk of intraparenchymal echodensity in very-low-birthweight neonates. Paediatr Perinat Epidemiol. 1998;12(4):408-21.

Wu YM, Colford JM Jr. Chorioaminionitis as a risk factor for cerebral palsy: A meta-analysis. JAMA. 2000;284:1417-24.

Dolk H, Pattenden S, Johnson A. Cerebral palsy, low birthweigth and socio economic deprivation: ine - qualities in a major cause of childhood disability. Paediatr Perinat Epidemiol. 2001;15:359-63.

Levison SW, Rothstein RP, Romanko MJ, Snyder MJ, Meyers RL, Vannucci SJ. Hypoxia/ischemia depletes the rat perinatal subventricular zone of oligodendrocyte progenitors and neural stem cells. Dev Neurosci. 2001;23(3):234-47.

Wiswell TE,Graziani IJ, Caddel JL, Vecchione N, Stanley C, Spitzer AR. Maternally administered magnesium sulfate (MgSO4) protects against early brain injury and long-term adverse neurodevelopmental outcomes in term infants: a prospective study. Pediatr Res. 1996;39:253.

Published

2002-08-09

Issue

Section

Original Article

How to Cite

1.
Pato TR, Pato TR, Souza DR de, Leite HP. Cerebral palsy epidemiology. Acta Fisiátr. [Internet]. 2002 Aug. 9 [cited 2024 Jul. 18];9(2):71-6. Available from: https://periodicos.usp.br/actafisiatrica/article/view/102365